Drug Profile
Carsatrin
Alternative Names: RWJ 24517; RWJ 25319; RWJ 25320Latest Information Update: 03 Oct 2006
Price :
$50
*
At a glance
- Originator Johnson & Johnson
- Class Antiarrhythmics; Cardiotonics; Small molecules
- Mechanism of Action Potassium channel antagonists; Sodium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 03 Oct 2006 Discontinued - Preclinical for Heart failure in USA (unspecified route)